ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,553Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 1269

$859K Total Retail Price of All Prescriptions

Rank: 39 out of 1269

408 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 408 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 408 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

3% of this provider’s 9,744 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 462 345 1 3
LEVOTHYROXINE SODIUM 439 274 2 4
HYDROCODONE-ACETAMINOPHEN 421 288 S3 3 20
LISINOPRIL 329 259 4 1
FUROSEMIDE 242 197 5 5
WARFARIN SODIUM 225 207 6 12
METFORMIN HCL 222 148 7 9
LEVOFLOXACIN 206 148 8 75
AMLODIPINE BESYLATE 198 187 9 2
PANTOPRAZOLE SODIUM 183 140 10 18
METOPROLOL SUCCINATE 182 136 11 13
HYDRALAZINE HCL 180 173 12 48
OMEPRAZOLE 179 109 13 8
METOPROLOL TARTRATE 173 150 14 6
ATORVASTATIN CALCIUM 164 125 15 7
TRAMADOL HCL 163 94 16 16
HYDROCHLOROTHIAZIDE 163 150 16 10
TRAZODONE HCL 162 102 18 36
POTASSIUM CHLORIDE 160 132 19 26
ZOLPIDEM TARTRATE 152 85 20 19
LACTULOSE 150 114 21 67
RISPERIDONE 146 89 22 43
GABAPENTIN 132 72 23 17
LOSARTAN POTASSIUM 126 109 24 15
ATENOLOL 122 122 25 14
LOVASTATIN 118 72 26 30
SERTRALINE HCL 118 60 26 23
TRIAMTERENE-HCTZ 115 48 28 69
MIRTAZAPINE 115 90 28 24
TAMSULOSIN HCL 111 98 30 31
CIPROFLOXACIN HCL 109 84 31 66
TORSEMIDE 109 101 31 234
OXYCODONE HCL 102 23 S2 33 34
AMOX TR-POTASSIUM CLAVULANATE 99 77 34 110
RANITIDINE HCL 92 45 35 27
AZITHROMYCIN 92 57 35 42
ACTOS 90 67 37 161
KLOR-CON M20 88 80 38 60
PRAVASTATIN SODIUM 87 55 39 11
DIGOXIN 85 85 40 62
DONEPEZIL HCL 85 85 40 22
JANUVIA 84 72 42 74
ACETAMINOPHEN-CODEINE 83 55 S3 43 98
CARBAMAZEPINE 83 12 43 148
SULFAMETHOXAZOLE-TRIMETHOPRIM 78 59 45 84
ALENDRONATE SODIUM 77 76 46 28
CARVEDILOL 76 65 47 29
IBUPROFEN 75 34 48 73
PRIMIDONE 75 49 48 209
GLIPIZIDE 71 62 50 37
NAMENDA 70 70 51 38
DIVALPROEX SODIUM 70 26 51 54
CARBIDOPA-LEVODOPA 70 70 51 78
OXYCODONE-ACETAMINOPHEN 67 51 S2 54 44
METOCLOPRAMIDE HCL 67 36 54 155
MELOXICAM 66 66 56 68
ADVAIR DISKUS 65 40 57 46
CYCLOBENZAPRINE HCL 63 38 R 58 93
VERAPAMIL ER 63 30 58 134
LEVETIRACETAM 62 25 60 55
PHENYTOIN SODIUM EXTENDED 61 15 61 137
CLOPIDOGREL 61 46 61 32
OXYBUTYNIN CHLORIDE ER 59 18 63 130
DILTIAZEM 24HR CD 57 45 64 146
SPIRIVA 57 41 64 64
MEGESTROL ACETATE 56 55 R 66 236
METFORMIN HCL ER 56 52 66 80
LANTUS 56 37 66 39
FENTANYL 55 25 S2 69 105
NITROFURANTOIN MONO-MACRO 55 55 69 198
ALLOPURINOL 55 52 69 49
PLAVIX 54 38 72 47
NYSTATIN-TRIAMCINOLONE 54 49 72 190
NEXIUM 53 26 74 41
PROAIR HFA 53 33 74 61
LUNESTA 53 21 74 269
PIOGLITAZONE HCL 52 43 R 77 383
CLONIDINE HCL 52 32 77 51
QUETIAPINE FUMARATE 51 32 79 53
FLUCONAZOLE 51 25 79 319
IPRATROPIUM BROMIDE 50 50 81 127
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.